Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
sotalol beta-1 adrenergic receptor small molecule NA drugbank , DGIDB Solutions[MeSHID:D012996]
Maintenance[MeSHID:D008283]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
pathologic fistula[MeSHID:D005402]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Paranasal Sinus Diseases[MeSHID:D010254]		 0.69 approved antagonist
sotalol adrenergic receptor beta-1 NA Successful target TTD , DGIDB Solutions[MeSHID:D012996]
Maintenance[MeSHID:D008283]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
pathologic fistula[MeSHID:D005402]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Paranasal Sinus Diseases[MeSHID:D010254]		 0.69 approved antagonist
sotalol adrenergic receptor beta-1 NA Successful target TTD , DGIDB Solutions[MeSHID:D012996]
Maintenance[MeSHID:D008283]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
pathologic fistula[MeSHID:D005402]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Paranasal Sinus Diseases[MeSHID:D010254]		 0.69 approved unknown
sotalol beta-2 adrenergic receptor small molecule NA drugbank , DGIDB Solutions[MeSHID:D012996]
Maintenance[MeSHID:D008283]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
pathologic fistula[MeSHID:D005402]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Paranasal Sinus Diseases[MeSHID:D010254]		 0.37 approved antagonist
sotalol potassium voltage-gated channel subfamily h member 2 small molecule NA drugbank , DGIDB Solutions[MeSHID:D012996]
Maintenance[MeSHID:D008283]
Heart Ventricle[MeSHID:D006352]
Atrial Fibrillation[MeSHID:D001281]
pathologic fistula[MeSHID:D005402]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Paranasal Sinus Diseases[MeSHID:D010254]		 0.13 approved inhibitor
click here to return to the previous page